Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.

@article{Klatte2014ImpactOA,
  title={Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.},
  author={Tobias Klatte and Evanguelos Xylinas and M. D. S. Rieken and Luis A Kluth and Morgan Roupr{\^e}t and Armin Pycha and Harun Fajkovi{\'c} and Christian Kevin Seitz and Pierre I. Karakiewicz and Yair Lotan and Marko Babjuk and Michela de Martino and Douglas S. Scherr and Shahrokh F Shariat},
  journal={The Journal of urology},
  year={2014},
  volume={191 5},
  pages={
          1238-43
        }
}
PURPOSE ABO blood type is an established prognostic factor for several malignancies but its role in bladder urothelial carcinoma is largely unknown. We determined whether ABO blood type is associated with the outcome of transurethral resection of nonmuscle invasive bladder urothelial carcinoma. MATERIALS AND METHODS We retrospectively studied ABO blood types in 931 patients with primary nonmuscle invasive bladder urothelial carcinoma treated with transurethral bladder resection with or… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy

  • World Journal of Urology
  • 2015
VIEW 11 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
HIGHLY INFLUENCED

Associations between ABO blood groups and biochemical recurrence after radical prostatectomy.

  • International journal of clinical and experimental medicine
  • 2015
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED